The top U.S. court without comment on Tuesday refused to consider J&J’s objections to a St. Louis jury’s 2018 finding its talc-based powder helped cause ovarian cancer in 20 women.
J&J prepared for the appeal’s denial by
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.